The University of Texas

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

The University of Texas
May 16, 2025, 12:28 | Blog
Giulio Draetta: A $150 million Gift from Kinder Foundation
Giulio Draetta, Chief Scientific Officer at The University of Texas M.D. Anderson Cancer Center, shared a…
May 14, 2025, 13:01 | Science
George Vlachogiannis: Machine Learning Model Predicting Cardiac Readmissions in Blood Cancer Patients
George Vlachogiannis, Managing Editor – Cancer Control at Sage, shared an article on LinkedIn: "Nguyen Le,…
Feb 3, 2025, 15:59 | Science
Tanvi Visal: Investigating the metastatic cascade in TNBC and uncovers CD38 as a potential interventional target
Tanvi Visal, PHD Candidate at The University of Texas MD Anderson Cancer Center UTHealth Graduate…
Oct 26, 2024, 14:59 | Insight
Peter Pisters: Welcoming MD Anderson’s Associate Vice President Jennifer Finkel
Peter Pisters, President of The University of Texas MD Anderson Cancer Center, shared a post…
Aug 31, 2024, 06:19 | Blog
MD Anderson Cancer Center is seeking a visionary leader to chair the Genitourinary Radiation Oncology department
Anne Tsao, Vice President of Academic Affairs at MD Anderson Cancer Center, shared on LinkedIn:…
Aug 22, 2024, 13:46 | Insight
Hagop Kantarjian: The latest advancements and progress in treating AML
Hagop Kantarjian shared a post on X: “Recording now available: The latest advancements and progress…
Aug 12, 2024, 13:41 | Blog
Rabab Hunaid Abbas: Dive deep into how small cellular clones can lead to significant health outcomes
Rabab Hunaid Abbas, Student Mentor at OneApply by Gyanberry, shared a post on LinkedIn: "…
Jul 1, 2024, 14:36 | Insight
Intratumoral immune triads in elimination of solid tumors
Patrick Hwu shared on X: "CD8+ 'killer' T cells can eliminate tumor cells. However, they…
Apr 24, 2024, 12:07 | Blog
Vivek Subbiah: One mission = Eradicate cancer
Vivek Subbiah shared on Twitter/X: "One of the greatest advantages of in person scientific meetings is…
Apr 20, 2024, 07:03 | Drugs
Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas…
Mar 21, 2024, 10:59 | Drugs
Guorong Ma: OmniNano Pharmaceuticals announce the execution of the Patent and Technology license with The University of Texas MD Anderson Cancer Center
Guorong Ma, Founding Chief Executive at OmniNano Pharmaceuticals, shared a post on LinkedIn: "At OmniNano…
Dec 24, 2023, 18:42 | Insight
Naveen Pemmaraju: Important new paper led by Alex Bataller and Tapan Kadia
Naveen Pemmaraju shared on X/Twitter: "Important New paper just out in Blood Advances led by…
Aug 23, 2023, 14:39 | Blog
Peter WT Pisters: Today I have been filled with pride in two separate airports thousands of miles apart.
Quoting Peter WT Pisters, President of MD Anderson Cancer Center on Twitter: "Today I have been…
All: 13 Posts: 1 - 100
Special Coverage